316 related articles for article (PubMed ID: 29705040)
1. Theranostics and metabolotheranostics for precision medicine in oncology.
Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
[TBL] [Abstract][Full Text] [Related]
2. Smart magnetic resonance imaging-based theranostics for cancer.
Brito B; Price TW; Gallo J; Bañobre-López M; Stasiuk GJ
Theranostics; 2021; 11(18):8706-8737. PubMed ID: 34522208
[TBL] [Abstract][Full Text] [Related]
3. Theranostics - a sure cure for cancer after 100 years?
Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
5. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle Diagnostics and Theranostics in the Clinic.
Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
[TBL] [Abstract][Full Text] [Related]
7. Review on Metal-Based Theranostic Nanoparticles for Cancer Therapy and Imaging.
Fernandes DA
Technol Cancer Res Treat; 2023; 22():15330338231191493. PubMed ID: 37642945
[TBL] [Abstract][Full Text] [Related]
8. Companion Diagnostics and Molecular Imaging.
Puranik AD; Kulkarni HR; Baum RP
Cancer J; 2015; 21(3):213-7. PubMed ID: 26049701
[TBL] [Abstract][Full Text] [Related]
9. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
10. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
11. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
12. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
Opoku-Damoah Y; Wang R; Zhou J; Ding Y
Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
[TBL] [Abstract][Full Text] [Related]
13. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
14. Learning from human metabolism for nanomedicine: a convertible bismuth-agent for tumour-selective theranostics.
Cao Q; Yang C; Yao Y; Li B; Liu J; Cao Z; Liu J; Xiao M
Mater Horiz; 2023 May; 10(5):1835-1841. PubMed ID: 36876968
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging and Spectroscopy in Cancer Theranostic Imaging.
Penet MF; Jin J; Chen Z; Bhujwalla ZM
Top Magn Reson Imaging; 2016 Oct; 25(5):215-221. PubMed ID: 27748706
[TBL] [Abstract][Full Text] [Related]
16. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
17. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract][Full Text] [Related]
18. Functional gadolinium-based nanoscale systems for cancer theranostics.
Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
[TBL] [Abstract][Full Text] [Related]
19. Magnetic mediators for ultrasound theranostics.
Józefczak A; Kaczmarek K; Bielas R
Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
[TBL] [Abstract][Full Text] [Related]
20. Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.
Chen Z; Krishnamachary B; Pachecho-Torres J; Penet MF; Bhujwalla ZM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1595. PubMed ID: 31642207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
